In an announcement on November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) revealed the new Maximum Fair Prices for 15 prescription drugs will reduce Medicare spending by 44% (about ...
Econostrum on MSN
Medicare price revolution: Which drugs will cost you less next year?
For many, these price reductions may represent a critical step in improving access to essential medications, especially as ...
Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care. As the costs of multiple sclerosis (MS) treatments continue to rise, it is ...
Lupin has received tentative USFDA approval to market generic Siponimod Tablets for treating multiple sclerosis, strengthening its US portfolio in speciality medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback